Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet
Marketer
Danavish Healthcare
Salt Composition
Fenofibrate (160mg) + Rosuvastatin (10mg)
Overview Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet
Lipitor-F (Fenofibrate/Rosuvastatin 160mg/10mg) combines two medications to reduce elevated blood fats (lipids). Prescribed when dietary changes alone prove insufficient, it lowers cholesterol and triglycerides, mitigating heart disease risk. This dual-action tablet may be taken with or without food, consistently at the same time daily for optimal efficacy. Dosage is individualized based on lipid levels and patient response. While high cholesterol often presents asymptomatically, discontinuation increases risk of cardiovascular complications. Regular lipid profile monitoring is crucial. Treatment involves this medication alongside a heart-healthy lifestyle: low-fat diet, exercise, smoking cessation, moderate alcohol consumption, and weight management. While normal eating is permitted, limit high-fat foods. Common, typically mild, side effects include nausea, abdominal discomfort, constipation, headache, gas, and myalgia. Persistent symptoms, jaundice, unusual bleeding, or severe muscle pain warrant immediate medical attention. Periodic liver function tests may be recommended. This medication is contraindicated in liver disease (e.g., abnormal liver function tests, persistent jaundice). Inform your doctor about kidney issues, pregnancy, breastfeeding intentions, or existing conditions. Diabetics should monitor blood glucose levels, as hyperglycemia may occur.
Primary Ingredients of Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet
No text was provided to rewrite.
Uses of Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet
Cardiovascular event prevention and hypercholesterolemia management
Major Benefits of Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Danavish Fenofibrate+Rosuvastatin 160mg/10mg tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent daily timing is recommended.
Common Side effects of Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet:
- Headache
- Muscle pain
- Constipation
- Abnormal liver function tests
- Joint pain
- Elevated creatine kinase
- Diabetes
How to use Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Danavish Fenofibrate+Rosuvastatin 160mg/10mg tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent daily timing is recommended for optimal results.
How Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet works:
Combifibrate-R, a 160mg/10mg tablet containing Fenofibrate and Rosuvastatin, combines two agents to reduce cholesterol. Fenofibrate decreases triglyceride levels, while Rosuvastatin inhibits the production of low-density lipoprotein (LDL) cholesterol, the undesirable type. Concurrently, both medications elevate high-density lipoprotein (HDL) cholesterol, the beneficial form.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Danavish Fenofibrate+Rosuvastatin 160mg/10mg tablets is unsafe.
PregnancyUNSAFE
Use of Danavish Fenofibrate/Rosuvastatin 160mg/10mg tablets is strongly contraindicated in pregnancy. Pregnant women should consult their physician; research in animals and pregnant women indicates substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
The combination medication Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet is likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Danavish Fenofibrate/Rosuvastatin 160mg/10mg tablets.
KidneyCAUTION
Fenofibrate and rosuvastatin 160mg/10mg tablets (Danavish) require careful consideration in patients with kidney impairment. Dosage modifications may be necessary. Physician consultation is advised. The medication is contraindicated for individuals with severe kidney disease.
LiverCAUTION
The combination of fenofibrate and rosuvastatin (160mg/10mg) should be administered cautiously to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients with severe or active liver disease.
What if you forget to take Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet :
Should you forget to take your Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Danavish Fenofibrate+Rosuvastatin 160mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



